SOX9 and Hepatic fibrosis: Felix A. Trogisch and their colleagues found that deletion of endothelial Sox9 inhibited fibrosis and organ dysfunction in 2 mouse models of heart failure and also in models of lung and liver fibrosis (Trogisch et al., 2024).